My research interests are centered around (1) predicting and advancing clinical outcomes in patients with non-Hodgkin lymphomas, most especially mantle cell lymphoma in the post-BTK inhibitor setting, and (2) translation of preclinical and early clinical data on drug transporters, particularly solute carrier family transporters, to therapeutic exploitation of their function in patients with lymphoma.
![Photo of Michael Buege](https://cancer.uillinois.edu/wp-content/uploads/2023/07/Michael-Buege-e1692646765348.jpeg)
Michael Buege, PharmD
Clinical Assistant Professor
Department of Pharmacy Practice
College of Pharmacy
Research Program
Cancer Prevention And Control (CPC)
Email: [email protected]